What is Oppenheimer's price target for EPIX?

Oppenheimer's latest stated price target for ESSA Pharma Inc. (EPIX) is $17, from its action on Jun 26, 2023.

What is Oppenheimer's rating on EPIX?

Oppenheimer rates EPIX Perform, a neutral rating, as of Nov 4, 2024.

When did Oppenheimer last change its view on EPIX?

On Nov 4, 2024, Oppenheimer downgrades to Perform from Outperform.

Oppenheimer EPIX price target and rating history

Oppenheimer rates ESSA Pharma Inc. (EPIX) Perform with a $17 price target, as of its latest action on Nov 4, 2024. It has published 3 rating actions on EPIX since August 2021, including 0 upgrades and 1 downgrade.

Current rating: Perform
Price target: $17
Median target, all firms: Too few
Actions on EPIX: 3

Oppenheimer price target on EPIX

Oppenheimer price target on EPIX, each point a stated target, August 2021 to June 2023.

Every Oppenheimer rating on EPIX

Nov 4, 2024
DowngradeOppenheimer downgrades to Perform from Outperform
Jun 26, 2023
ResumeOppenheimer resumes coverage at Outperform, price target $17
Aug 17, 2021
ReiterateOppenheimer cuts its price target to $22 from $36, keeps Outperform

Questions about Oppenheimer and EPIX

What is Oppenheimer's price target for EPIX?: Oppenheimer's latest stated price target for ESSA Pharma Inc. (EPIX) is $17, from its action on Jun 26, 2023.
What is Oppenheimer's rating on EPIX?: Oppenheimer rates EPIX Perform, a neutral rating, as of Nov 4, 2024.
When did Oppenheimer last change its view on EPIX?: On Nov 4, 2024, Oppenheimer downgrades to Perform from Outperform.

All Oppenheimer ratings EPIX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.